Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.

Kyra BokkersEveline M A BleikerJacob P HoogendamMary E VelthuizenHenk W R SchreuderCornelis G GeresteinJoost G LangeJacqueline A LouwersMarco J KoudijsMargreet G E M AusemsRonald P Zweemer

Published in: Hereditary cancer in clinical practice (2022)

Mainstream genetic testing is an acceptable approach to meet the increase in genetic testing among women with epithelial ovarian cancer.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported